Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2019

01-08-2019 | Editorial

Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?

Authors: Pierre-Yves Marie, MD, PhD, Sophie Visvikis-Siest, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2019

Login to get access

Excerpt

Although reliable information on left ventricular (LV) perfusion can be provided at stress with several imaging techniques, myocardial perfusion SPECT imaging (MPI) has the major advantages of being both relatively simple to perform and analyze, with very rare contraindications, and of providing a wide variety of stress and injection protocols, hence allowing this technique to be adapted to each patient and to different indications.1,2 To these advantages, we can add its current high image quality owing to recent technical and methodological advances—i.e., semiconductor detectors, new collimation systems, and/or novel reconstruction software 1,2—thus making MPI more reliable and relevant compared to the past. Moreover, as it can now be performed with a much lower radiation exposure, this evolution is particularly favorable for the growing number of patients referred for repeated ionizing procedures throughout the course of their life.3
Literature
1.
go back to reference Imbert L, Marie PY. CZT cameras: A technological jump for myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:894–6.CrossRefPubMed Imbert L, Marie PY. CZT cameras: A technological jump for myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:894–6.CrossRefPubMed
2.
go back to reference Perrin M, Djaballah W, Moulin F, Claudin M, Veran N, Imbert L, et al. Stress-first protocol myocardial perfusion SPECT imaging with semiconductor cameras: High diagnostic performances with significant reduction in patient radiation doses. Eur J Nucl Med Mol Imaging. 2015;42:1004–11.CrossRefPubMed Perrin M, Djaballah W, Moulin F, Claudin M, Veran N, Imbert L, et al. Stress-first protocol myocardial perfusion SPECT imaging with semiconductor cameras: High diagnostic performances with significant reduction in patient radiation doses. Eur J Nucl Med Mol Imaging. 2015;42:1004–11.CrossRefPubMed
3.
go back to reference Einstein AJ1, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304(19):2137-2144. Einstein AJ1, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304(19):2137-2144.
4.
go back to reference Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2014;21:192–220.CrossRef Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2014;21:192–220.CrossRef
5.
go back to reference Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: Possible causes and implications. Circ Res. 2017;120:366–80.CrossRefPubMedPubMedCentral Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: Possible causes and implications. Circ Res. 2017;120:366–80.CrossRefPubMedPubMedCentral
7.
go back to reference Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.CrossRefPubMed Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.CrossRefPubMed
8.
go back to reference Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012;103:1–8. Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012;103:1–8.
9.
go back to reference Hamrefors V. Common genetic risk factors for coronary artery disease: New opportunities for prevention? Clin Physiol Funct Imaging. 2017;37:243–54.CrossRefPubMed Hamrefors V. Common genetic risk factors for coronary artery disease: New opportunities for prevention? Clin Physiol Funct Imaging. 2017;37:243–54.CrossRefPubMed
10.
11.
go back to reference Ndiaye NC, Azimi Nehzad M, El Shamieh S, Stathopoulou MG, Visvikis-Siest S. Cardiovascular diseases and genome-wide association studies. Clin Chim Acta. 2011;412:1697–701.CrossRefPubMed Ndiaye NC, Azimi Nehzad M, El Shamieh S, Stathopoulou MG, Visvikis-Siest S. Cardiovascular diseases and genome-wide association studies. Clin Chim Acta. 2011;412:1697–701.CrossRefPubMed
12.
go back to reference Visvikis-Siest S, Stathopoulou MG, Ndiaye NC. Common mutations and polymorphisms predicting adverse cardiovascular events: Current view. Pharmacogenomics. 2012;13:1875–8.CrossRefPubMed Visvikis-Siest S, Stathopoulou MG, Ndiaye NC. Common mutations and polymorphisms predicting adverse cardiovascular events: Current view. Pharmacogenomics. 2012;13:1875–8.CrossRefPubMed
13.
17.
go back to reference Turan N, Katari S, Coutifaris C, Sapienza C. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics. 2010;5:16–9.CrossRefPubMedPubMedCentral Turan N, Katari S, Coutifaris C, Sapienza C. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics. 2010;5:16–9.CrossRefPubMedPubMedCentral
19.
go back to reference Zhao Y, Zeng D. Recent development on statistical methods for personalized medicine discovery. Front Med. 2013;7:102–10.CrossRefPubMed Zhao Y, Zeng D. Recent development on statistical methods for personalized medicine discovery. Front Med. 2013;7:102–10.CrossRefPubMed
20.
go back to reference Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: Current state and future directions. Heart Fail Rev. 2017;22:441–53.CrossRefPubMed Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: Current state and future directions. Heart Fail Rev. 2017;22:441–53.CrossRefPubMed
Metadata
Title
Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?
Authors
Pierre-Yves Marie, MD, PhD
Sophie Visvikis-Siest, PhD
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1240-9

Other articles of this Issue 4/2019

Journal of Nuclear Cardiology 4/2019 Go to the issue